These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 2194428)

  • 1. Measurement and clinical importance of antibodies to glycosphingolipids.
    Marcus DM
    Ann Neurol; 1990; 27 Suppl():S53-5. PubMed ID: 2194428
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glycosphingolipid antibodies and blood-nerve barrier in autoimmune demyelinative neuropathy.
    Kanda T; Yamawaki M; Iwasaki T; Mizusawa H
    Neurology; 2000 Apr; 54(7):1459-64. PubMed ID: 10751258
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-GM1 antibodies in patients with Guillain-Barré syndrome.
    van den Berg LH; Marrink J; de Jager AE; de Jong HJ; van Imhoff GW; Latov N; Sadiq SA
    J Neurol Neurosurg Psychiatry; 1992 Jan; 55(1):8-11. PubMed ID: 1548508
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibodies to gangliosides in Guillain-Barré syndrome: specificity and relationship to clinical features.
    Gregson NA; Koblar S; Hughes RA
    Q J Med; 1993 Feb; 86(2):111-7. PubMed ID: 8464986
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human IgM monoclonal proteins that bind 3-fucosyllactosamine, asialo-GM1, and GM1.
    Marcus DM; Perry L; Gilbert S; Preud'homme JL; Kyle R
    J Immunol; 1989 Nov; 143(9):2929-32. PubMed ID: 2572647
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanisms of action of anti-GM1 and anti-GQ1b ganglioside antibodies in Guillain-Barré syndrome.
    Willison HJ; O'Hanlon G; Paterson G; O'Leary CP; Veitch J; Wilson G; Roberts M; Tang T; Vincent A
    J Infect Dis; 1997 Dec; 176 Suppl 2():S144-9. PubMed ID: 9396699
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Measurement of antiganglioside autoantibodies by immunodot-blot assay: clinical importance in peripheral neuropathies].
    Caudie C; Vial C; Petiot P; Bancel J; Later R; Gonnaud PM
    Ann Biol Clin (Paris); 1999; 57(5):579-88. PubMed ID: 10518060
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acute motor neuropathy with antibodies to GM1 ganglioside.
    Gregson NA; Jones D; Thomas PK; Willison HJ
    J Neurol; 1991 Dec; 238(8):447-51. PubMed ID: 1779252
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Search for antibodies to neutral glycolipids in sera of patients with Guillain-Barré syndrome.
    Ilyas AA; Mithen FA; Chen ZW; Cook SD
    J Neurol Sci; 1991 Mar; 102(1):67-75. PubMed ID: 1856733
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Autoantibodies to peripheral nerve glycosphingolipids SPG, SLPG, and SGPG in Guillain-Barré syndrome and chronic inflammatory demyelinating polyneuropathy.
    Yuki N; Tagawa Y; Handa S
    J Neuroimmunol; 1996 Oct; 70(1):1-6. PubMed ID: 8862128
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-GM1 ganglioside antibodies with differing fine specificities in patients with multifocal motor neuropathy.
    Baba H; Daune GC; Ilyas AA; Pestronk A; Cornblath DR; Chaudhry V; Griffin JW; Quarles RH
    J Neuroimmunol; 1989 Dec; 25(2-3):143-50. PubMed ID: 2584393
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-glycosphingolipid autoantibodies in rheumatologic disorders.
    Zeballos RS; Fox RI; Cheresh DA; McPherson RA
    J Clin Lab Anal; 1994; 8(6):378-84. PubMed ID: 7869176
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibodies in sera from patients with inflammatory demyelinating polyradiculoneuropathy react with ganglioside LM1 and sulphatide of peripheral nerve myelin.
    Fredman P; Vedeler CA; Nyland H; Aarli JA; Svennerholm L
    J Neurol; 1991 Apr; 238(2):75-9. PubMed ID: 1856740
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ELISA-type titertray assay of IgM anti-GM1 autoantibodies.
    Bech E; Jakobsen J; Orntoft TF
    Clin Chem; 1994 Jul; 40(7 Pt 1):1331-4. PubMed ID: 8013109
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increase in asialoganglioside- and monosialoganglioside-reactive antibodies in chronic Chagas' disease patients.
    Avila JL; Rojas M; Avila A
    Am J Trop Med Hyg; 1998 Mar; 58(3):338-42. PubMed ID: 9546415
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Measurement and significance of antibodies against GM1 ganglioside. Report of a workshop, 18 April 1989, Chicago, IL, U.S.A.
    Marcus DM; Latov N; Hsi BP; Gillard BK
    J Neuroimmunol; 1989 Dec; 25(2-3):255-9. PubMed ID: 2584398
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Guillain-Barre syndrome and antibodies to ganglioside GM1. Case report].
    Trisković I; Dimitrijević Lj; Rakocević-Stojanović V; Trikić R; Apostolski S
    Srp Arh Celok Lek; 1996; 124(7-8):210-3. PubMed ID: 9102850
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High affinity as a disease determinant factor in anti-GM(1) antibodies: comparative characterization of experimentally induced vs. disease-associated antibodies.
    Lopez PH; Villa AM; Sica RE; Nores GA
    J Neuroimmunol; 2002 Jul; 128(1-2):69-76. PubMed ID: 12098512
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Antiganglioside antibodies: when, which and for what].
    Gallardo E; Rojas-García R; Belvís R; Serrano-Munuera C; Ortiz E; Ortiz N; Grau J; Illa I
    Neurologia; 2001; 16(7):293-7. PubMed ID: 11485721
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Close association of IgA anti-ganglioside antibodies with antecedent Campylobacter jejuni infection in Guillain-Barré and Fisher's syndromes.
    Koga M; Yuki N; Takahashi M; Saito K; Hirata K
    J Neuroimmunol; 1998 Jan; 81(1-2):138-43. PubMed ID: 9521615
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.